These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7612259)

  • 21. Cytokine stimulation by Pseudomonas aeruginosa--strain variation and modulation by pulmonary surfactant.
    Bufler P; Schikor D; Schmidt B; Griese M
    Exp Lung Res; 2004; 30(3):163-79. PubMed ID: 15195551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NET formation induced by Pseudomonas aeruginosa cystic fibrosis isolates measured as release of myeloperoxidase-DNA and neutrophil elastase-DNA complexes.
    Yoo DG; Floyd M; Winn M; Moskowitz SM; Rada B
    Immunol Lett; 2014 Aug; 160(2):186-94. PubMed ID: 24670966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of Pseudomonas aeruginosa lipopolysaccharide immunoadsorbents to prepare high potency, mono-specific antibodies.
    Fick RB; Naegel GP; Reynolds HY
    J Immunol Methods; 1980; 38(1-2):103-16. PubMed ID: 6778926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of tumour necrosis factor from lipopolysaccharide-stimulated human mononuclear cells by enzyme-linked immunosorbent assay and cytotoxicity bioassay.
    Fomsgaard A; Worsaae H; Bendtzen K
    Scand J Immunol; 1988 Feb; 27(2):143-7. PubMed ID: 3340824
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An ELISA to detect antipseudomonal IgA antibodies in sera of patients with cystic fibrosis.
    Brett MM; Ghoneim AT; Littlewood JM
    J Clin Pathol; 1988 Oct; 41(10):1130-4. PubMed ID: 3142934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of systemic immune complexes, complement activation, and antibodies to Pseudomonas aeruginosa lipopolysaccharide and exotoxin A with mortality in cystic fibrosis.
    Moss RB; Hsu YP; Lewiston NJ; Curd JG; Milgrom H; Hart S; Dyer B; Larrick JW
    Am Rev Respir Dis; 1986 Apr; 133(4):648-52. PubMed ID: 3083745
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharides and exotoxin A in patients with cystic fibrosis or bacteremia.
    Brauner A; Cryz SJ; Granström M; Hanson HS; Löfstrand L; Strandvik B; Wretlind B
    Eur J Clin Microbiol Infect Dis; 1993 Jun; 12(6):430-6. PubMed ID: 8359163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunoglobulin allotypes and IgG subclass antibody response to Pseudomonas aeruginosa antigens in chronically infected cystic fibrosis patients.
    Pressler T; Pandey JP; Espersen F; Pedersen SS; Fomsgaard A; Koch C; Høiby N
    Clin Exp Immunol; 1992 Nov; 90(2):209-14. PubMed ID: 1424275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The priming effects of the products of stimulated mononuclear cells on the response of neutrophils to C5a des arg.
    Crouch S; Fletcher J
    Br J Haematol; 1991 Feb; 77(2):158-64. PubMed ID: 2004016
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunoglobulin-G subclasses in cystic fibrosis. IgG2 response to Pseudomonas aeruginosa lipopolysaccharide.
    Fick RB; Olchowski J; Squier SU; Merrill WW; Reynolds HY
    Am Rev Respir Dis; 1986 Mar; 133(3):418-22. PubMed ID: 3082264
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mucoid Pseudomonas aeruginosa growing in a biofilm in vitro are killed by opsonic antibodies to the mucoid exopolysaccharide capsule but not by antibodies produced during chronic lung infection in cystic fibrosis patients.
    Meluleni GJ; Grout M; Evans DJ; Pier GB
    J Immunol; 1995 Aug; 155(4):2029-38. PubMed ID: 7636254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IgG subclass antibodies to Pseudomonas aeruginosa in sera from patients with chronic Ps. aeruginosa infection investigated by ELISA.
    Pressler T; Pedersen SS; Espersen F; Høiby N; Koch C
    Clin Exp Immunol; 1990 Sep; 81(3):428-34. PubMed ID: 2118845
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulating immune complexes in cystic fibrosis.
    Berdischewsky M; Pollack M; Young LS; Chia D; Osher AB; Barnett EV
    Pediatr Res; 1980 Jun; 14(6):830-3. PubMed ID: 6773019
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lower levels of whole blood LPS-stimulated cytokine release are associated with poorer clinical outcomes in surgical ICU patients.
    Heagy W; Nieman K; Hansen C; Cohen M; Danielson D; West MA
    Surg Infect (Larchmt); 2003; 4(2):171-80. PubMed ID: 12906717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection.
    Preston MJ; Gerçeker AA; Koles NL; Pollack M; Pier GB
    Invest Ophthalmol Vis Sci; 1997 Jun; 38(7):1418-25. PubMed ID: 9191605
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pseudomonas aeruginosa antibodies in blood spots from patients with cystic fibrosis.
    Thanasekaraan V; Wiseman MS; Rayner RJ; Hiller EJ; Shale DJ
    Arch Dis Child; 1989 Nov; 64(11):1599-603. PubMed ID: 2513779
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Porins of Pseudomonas aeruginosa induce release of tumor necrosis factor alpha and interleukin-6 by human leukocytes.
    Cusumano V; Tufano MA; Mancuso G; Carbone M; Rossano F; Fera MT; Ciliberti FA; Ruocco E; Merendino RA; Teti G
    Infect Immun; 1997 May; 65(5):1683-7. PubMed ID: 9125547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of the adherence of Pseudomonas aeruginosa to epithelial cells by IgG subclass antibodies.
    Morrin M; Reen DJ
    J Med Microbiol; 1993 Dec; 39(6):459-66. PubMed ID: 8246266
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Secretion of IL-1 beta, TNF-alpha, IL-8 and IL-1ra by human polymorphonuclear leukocytes in response to lipopolysaccharides from periodontopathic bacteria.
    Yoshimura A; Hara Y; Kaneko T; Kato I
    J Periodontal Res; 1997 Apr; 32(3):279-86. PubMed ID: 9138193
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immune complexes from immunized mice and infected cystic fibrosis patients mediate murine and human T cell killing of hybridomas producing protective, opsonic antibody to Pseudomonas aeruginosa.
    Pier GB; Takeda S; Grout M; Markham RB
    J Clin Invest; 1993 Mar; 91(3):1079-87. PubMed ID: 8450038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.